胃饥饿素与神经体液拮抗剂在治疗心肺疾病相关性恶病质中的应用 - Suppr

Suppr

超能文献

Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease.

作者信息

Lainscak Mitja, Andreas Stefan, Scanlon Paul D, Somers Virend K, Anker Stefan D

出版信息

Intern Med. 2006;45(13):837. doi: 10.2169/internalmedicine.45.1867. Epub 2006 Aug 1.

DOI:10.2169/internalmedicine.45.1867

PMID:16880713

Abstract

摘要

相似文献

Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease.

Intern Med. 2006;45(13):837. doi: 10.2169/internalmedicine.45.1867. Epub 2006 Aug 1.

Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.

Intern Med. 2006;45(3):127-34. doi: 10.2169/internalmedicine.45.1402. Epub 2006 Mar 1.

Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches.

Curr Heart Fail Rep. 2005 Dec;2(4):198-203. doi: 10.1007/BF02696650.

Treatment of cachexia with ghrelin in patients with COPD.

Chest. 2005 Sep;128(3):1187-93. doi: 10.1378/chest.128.3.1187.

Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure.

Curr Opin Pharmacol. 2003 Apr;3(2):146-51. doi: 10.1016/s1471-4892(03)00013-4.

Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.

Circulation. 2004 Dec 14;110(24):3674-9. doi: 10.1161/01.CIR.0000149746.62908.BB. Epub 2004 Nov 29.

Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia.

J Am Geriatr Soc. 2008 Dec;56(12):2363-5. doi: 10.1111/j.1532-5415.2008.02031.x.

Mechanism and novel therapeutic approaches to wasting in chronic disease.

Maturitas. 2013 Jul;75(3):199-206. doi: 10.1016/j.maturitas.2013.03.014. Epub 2013 May 9.

Emerging results of anticatabolic therapy with ghrelin.

Curr Opin Clin Nutr Metab Care. 2007 May;10(3):278-83. doi: 10.1097/MCO.0b013e3280fa8208.

Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect.

Peptides. 2011 Nov;32(11):2295-300. doi: 10.1016/j.peptides.2011.05.018. Epub 2011 May 23.

引用本文的文献

An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 2014 May 1;189(9):e15-62. doi: 10.1164/rccm.201402-0373ST.

Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.

J Cachexia Sarcopenia Muscle. 2011 Jun;2(2):81-86. doi: 10.1007/s13539-011-0023-9. Epub 2011 Mar 1.

Feasibility of transcutaneous electrical muscle stimulation in acute exacerbation of COPD.

Wien Klin Wochenschr. 2011 Jun;123(11-12):384-7. doi: 10.1007/s00508-011-1587-2. Epub 2011 May 25.

Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia.

J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):159-167. doi: 10.1007/s13539-010-0012-4. Epub 2010 Dec 17.

Ghrelin for cachexia.

J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):169-176. doi: 10.1007/s13539-010-0011-5. Epub 2010 Dec 17.

Current and potential roles of ghrelin in clinical practice.

J Endocrinol Invest. 2010 Dec;33(11):823-38. doi: 10.1007/BF03350350.

The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.

Wien Klin Wochenschr. 2009;121(9-10):309-13. doi: 10.1007/s00508-009-1185-8.

Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review.

Wien Klin Wochenschr. 2009;121(9-10):293-6. doi: 10.1007/s00508-009-1194-7.

COPD is not COPD is not allergy.

Wien Klin Wochenschr. 2009;121(9-10):289-92. doi: 10.1007/s00508-009-1189-4.

[Percutaneous aortic valve replacement - pro].

Herz. 2009 Mar;34(2):124-9. doi: 10.1007/s00059-009-3213-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验